About Quintiles
Quintiles helps pharmaceutical, biotechnology and medical device companies develop and market innovative therapies. What drives us: the promise of medical breakthroughs that will improve and save lives.
We invite you to explore the possibilities of partnering with Quintiles Clinical Research Organization (CRO), Commercial Services Organization (CSO) and Consulting throughout the product lifecycle.
Clinical CRO Services
Accelerated start-up? Simultaneous regulatory submissions? Data integration? Quintiles’ therapeutic expertise, trial management experience and global reach as a contract research organization (CRO) can deliver what you need, when you need it. Learn more
What's New: Alliance with AstraZeneca
Quintiles will assume the operational responsibilities for the majority of AstraZeneca’s clinical pharmacology delivery across multiple therapeutic areas and around the globe.
What's New: Guy’s & St Thomas’ NHS Foundation Trust & King’s College London sign collaborative agreement with Quintiles
Commercial Services
Maximize your pharmaceutical sales and marketing results with the Quintiles CSO and Commercial Services teams at Innovex. We integrate skilled resources with targeted, performance-based services for smarter solutions. Learn more
What's New: Quintiles and Healthcare at Home Form an Innovative Healthcare Joint Venture in Europe
The JV, named Healthcare at Home Europe, will develop homecare services to allow patients to receive specialist treatments when and where its most convenient for them; such as in the comfort of their own homes or at their workplace.
Consulting
Your success depends on making better strategic decisions based on data-driven advice. We combine multidimensional pharmaceutical, medical device and biotechnology industry and operational expertise with process and technology strategy experience to help transform your business model, optimize productivity and maximize value. Learn more.
What's New: Three key appointments in US Regulatory and Quality consulting practice announced.
What's New: Report titled, Rewarding Innovation and Value: What is the Role of Comparative Effectiveness Research
Experts explore the complex issue of comparative effectiveness research (CER) and its strategic importance in successful and efficient biopharmaceutical development. Read more.
Partnership & Alliances
Quintiles’ NovaQuest helped Lilly achieve one of the most successful blockbuster launches in the industry, enabled Solvay to reduce costs and accelerate development time, and provided ProStrakan with its first US sales force. Learn how a NovaQuest partnership can transform your business to respond to today’s challenges. Learn more
What's New: Strategic alliance with Eisai Co., Ltd. announced
In this alliance, Quintiles’ oncology experts will conduct Phase II proof-of-concept studies for 11 solid tumor indications. The goal? Determine the efficacy of the products in the shortest possible time in order to bring therapies to market faster for the benefit of cancer patients worldwide.